Roche Diagnostics

Waiver for rare disease drugs brings little relief: Pharma sector

Industry bats for extending exemption to drugs that are already commercially available in India

TMSEp265: Fintechs, Q&A with Roche family, capital goods stocks, SOVA virus

Why are regulators uneasy about fintechs' dominance? Can Roche stay ahead of the competition in the next 125 yrs? Is a re-rating on the cards for capital goods stocks? What is SOVA virus? Answers here

Can Roche stay ahead of the competition in the next 125 years?

Pharma giant Roche believes, its ability to reinvent itself through innovation was behind its success. Business Standard's Sohini Das and Nivedita Mookerji spoke to the members of its founding family

India's Covid vaccination programme stunning: Roche's Hoffmann, Duschmale

'They (the next 125 years) look more challenging than the past 125 years. The world has changed. We have to make quicker decisions'

UK's Covid testing system face disruptions by Roche supply chain glitch

LONDON (Reuters) - Britain's COVID-19 testing system faced more disruption on Wednesday after logistical problems at a Roche warehouse delayed the dispatch of some of the Swiss pharmaceutical giant's products.

Roche mixes Actemra with Gilead's remdesivir in Covid-19 trial

Actemra and remdesivir are being used separately in some settings and clinical trials

Mumbai docs try Biocon and Roche's biologic drugs on critical Covid cases

Two repurposed drugs for rheumatoid arthritis and psoriasis are being tried on over 100 patients in Mumbai

Switzerland is country partner for BioAsia event on February 17-19

BioAsia is an annual event in which stakeholders in the lifesciences sector discuss new innovations and explore possibility of business collaborations in the sector

Trend shifting from treatment to prevention, screening: Shravan Subramanyam

We recently launched digital pathology where everything is now done digitally, says Subramanyam